The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients

The Value of Interleukin-6 among Several Inflammatory Markers as a Predictor of Respiratory Failure in COVID-19 Patients

Patients with coronavirus disease 2019 (COVID-19) develop severe respiratory failure within a short period during the clinical course. It is essential to predict respiratory deterioration in the short term. We investigated the use of inflammatory markers to predict respiratory distress within three...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diagnostics (Basel) 2021-07, Vol.11 (8), p.1327
Hauptverfasser: Fujino, Mitsuhiro, Ishii, Michiyo, Taniguchi, Takuya, Chiba, Hiroya, Kimata, Masaki, Hitosugi, Masahito
Format: Artikel
Sprache:eng
Schlagworte:
Blood
Body mass index
Coronaviruses
COVID-19
Cytokines
Immunoassay
inflammatory marker
interleukin-6
Laboratories
novel coronavirus disease
Pandemics
Patients
Respiratory failure
Severe acute respiratory syndrome coronavirus 2
Ventilation
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Patients with coronavirus disease 2019 (COVID-19) develop severe respiratory failure within a short period during the clinical course. It is essential to predict respiratory deterioration in the short term. We investigated the use of inflammatory markers to predict respiratory distress within three days from their analysis in COVID-19 patients. This retrospective observational study included 81 patients admitted with COVID-19. Patients were divided into two groups according to whether the maximum fraction of inspired oxygen (FiO2) for three days from the blood marker measurements was ≥0.4 (high FiO2 group; HFG) or
ISSN:2075-4418
2075-4418
DOI:10.3390/diagnostics11081327